PUBLISHER: Value Market Research | PRODUCT CODE: 1306534
PUBLISHER: Value Market Research | PRODUCT CODE: 1306534
The global demand for Spinal Cord Stimulation Devices Market is presumed to reach the market size of nearly USD 6.12 BN by 2030 from USD 2.98 BN in 2022 with a CAGR of 9.4% under the study period 2023 - 2030.
Spinal cord stimulation devices are medical implants used to manage chronic pain conditions, particularly when other treatments have been ineffective. These devices work by delivering electrical impulses to the spinal cord, which helps in modulating or blocking pain signals before reaching the brain.
The rising prevalence of chronic pain conditions, such as failed back surgery syndrome and neuropathic pain, contributes to the demand for effective pain management solutions. These devices are recognised as a viable treatment option for these conditions. sA growing awareness and acceptance of spinal cord stimulation therapy among patients and healthcare providers is further driving the market. Technological advancements have improved device features, enhancing patient comfort and pain management outcomes. As the focus on reducing opioid use and addressing the opioid crisis increases, these devices offer a non-pharmacological alternative, making them an attractive option. The ageing population also significantly drives market demand, as chronic pain conditions are more prevalent among older adults. Favourable reimbursement policies and coverage for spinal cord stimulation therapy positively impact the market, encouraging healthcare providers to offer these devices as a treatment option. Furthermore, patient preferences for improved quality of life drive the demand for spinal cord stimulation devices, as they can provide pain relief, reduce medication dependency, and enhance functional abilities.
The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of spinal cord stimulation devices. The growth and trends of spinal cord stimulation devices industry provide a holistic approach to this study.
This section of the spinal cord stimulation devices market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Spinal Cord Stimulation Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the spinal cord stimulation devices market include Boston Scientific Corporation, St. Jude Medical, Inc, (Abbott), Neurosigma Inc, Nevro Corp, Synapse Biomedical Inc, Medtronic. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.